November 13, 2023

Number range CHAPTER

[CURRICULUM VITAE]{.underline}

[Name]{.underline}: Stephen K. Anderson, Ph.D.

[Date and Place of Birth]{.underline}: March 16, 1960; St. Hyacinthe,
Quebec, Canada

[Citizenship]{.underline}: Canadian

[Marital Status]{.underline}: Married; 2 children

[Education]{.underline}:

1982 B.S. (Genetics), University of Western Ontario,

London, Ontario

1986 Ph.D., Department of Biochemistry, University of Western Ontario,
London, Ontario

Thesis Title: Structure and Function of the Rous Sarcoma

Virus [src]{.underline} Gene and the Human c-[src]{.underline} Gene.

[Brief Chronology of Employment]{.underline}:

> 1986-1989 National Cancer Institute Fellowship Division of Molecular

Immunology and Neurobiology, Mount Sinai Hospital Research Institute,
Toronto, Canada

Suprv.: Dr. J.C. Roder

1988-1989 Visiting Scientist, Laboratory of Experimental Immunology,
National Cancer Institute, Frederick Cancer Research and Development
Center, Frederick, MD

1989-1992 Project Leader, Division of Molecular Immunology,
Biotechnology Research Institute, Montreal, Quebec, Canada

1992-1994 Visiting Associate, Cellular and Molecular Immunology Section,
Laboratory of Experimental Immunology, BRMP, National Cancer Institute,
Frederick Cancer Research and Development Center, Frederick, MD

1994--Present Principal Investigator, Biological Carcinogenesis and
Development Program, SAIC-Frederick, Laboratory of Experimental
Immunology, NCI-Frederick, Frederick, MD

[Honors and Other Special Scientific Recognition]{.underline}:

1983 Cancer Research Society (Montreal) Studentship

1983-1986 National Cancer Institute of Canada Studentship

1984 Morris Kroll Memorial Award for Cancer Research

1986 Medical Research Council of Canada Fellowship

1986-1989 National Cancer Institute of Canada Fellowship

1987 William Zaharia Award for Biochemistry

[Research Grants]{.underline}:

1989-1990 \"Ras Oncogene Induced NK Target Structures.\"

Funded by the Cancer Research Society, Montreal.

1st year: \$46,000; 2nd year: \$52,000.

2011. "NK Cells, Their Receptors and Unrelated Donor Transplants."

> POI CA111412 (J. Miller). Co-Investigator

[Invited Presentations]{.underline}:

> April 2003 Invited Guest Speaker, "Stochastic Switches Control Ly49
> Gene Activation", Department of Microbiology and Immunology, Dalhousie
> University, Halifax
>
> May 2003 Invited Guest Speaker, "Stochastic Switches Control Ly49 Gene
> Activation", AAI Transcriptional Regulation of the Immune System
> Symposium, Denver, CO
>
> Oct 2003 Invited Guest Speaker, "Chance and Necessity: A Stochastic
> Switch Explains Variegated Receptor Expression", Immunology and Cell
> Biology Seminar Series, NCI-Frederick, MD

## 

> Oct 2003 Invited Guest Speaker, "Probabilistic Switches: A Simple
> Explanation for Variegated Gene Expression in the Immune System", H.
> Lee Moffitt Comprehensive Cancer Center and Research Institute, Tampa,
> FL
>
> Feb 2004 Invited Guest Speaker," A Novel Paradigm for Programmed
> Decision-Making in Eukaryotes: Identification of Probabilistic
> Transcriptional Switches", Department Cell Biology and Neuroscience,
> Rutgers University, NJ
>
> Feb 2004 Invited Guest Speaker, "Playing Dice with NK cells:
> Probabilistic Switches Control Ly49 Expression", NIH Immunology
> Interest Group Seminar Series, Bethesda, MD
>
> July 2004 Invited Guest Speaker, "A Critical Role for NF-kB/p65 in
> Establishing the Ly49 Repertoire of Natural Killer Cells", 12th
> International Congress of Immunology, Montreal, Canada
>
> Sept 2004 Invited Guest Speaker, "Variegated Expression of Class I MHC
> Receptors on NK Cells: Some Things are Best Left to Chance", Division
> of Basic Science, Fox Chase Cancer Center, Philadelphia, PA
>
> Sept 2004 Invited Guest Speaker, "Expression of Class I Receptors on
> NK Cells: Some Things are Best Left to Chance", Department of
> Immunology, Univ. Toronto, Canada
>
> Oct 2004 Invited Guest Speaker, "Variegated Expression of Class I MHC
> Receptors on NK Cells: Some Things are Best Left to Chance", Univ.
> Minnesota Cancer Center, Minneapolis, MN
>
> Nov 2004 Invited Guest Speaker, "Identification of Probabilistic
> Transcriptional Switches in the Ly49 Gene Cluster: A Eukaryotic
> Mechanism for Selective Gene Activation", School of Biosciences,
> University of Newcastle, UK
>
> Nov 2004 Invited Guest Speaker, "Identification of Probabilistic
> Transcriptional Switches in the Ly49 Gene Cluster: A Eukaryotic
> Mechanism for Selective Gene Activation", Babraham Institute,
> Cambridge, UK
>
> Feb 2005 Invited Guest Speaker, "Chance and Necessity: Generation of
> the Class I MHC Receptor Repertoire", Immunology and Virology Program,
> Univ. Massachusetts Medical School, Worchester, MA
>
> Feb 2005 Invited Guest Speaker, "Chance and Necessity: Generation of
> the Class I MHC Receptor Repertoire", Department of Microbiology and
> Immunology, Univ. Nevada, Reno, NV
>
> March 2005 Invited Guest Speaker, "Biology of NK Cells:  What Is the
> Relationship between NK Cells and Cancer? Will an Increased Number
> and/or Function of NK Cells Result in Lower Cancer Resistance?",
> ***Immunonutrition: Enhancing Tumoricidal Cell Activity Workshop,
> Bethesda, MD***
>
> April 2005 Invited Guest Speaker, "Chance and Necessity: Probabilistic
> Switches in Class I MHC Receptors", Society of Natural Immunity
> Symposium at AAI/FASEB, San Diego, CA

# Aug 2005 Invited Guest Speaker, "Identification of Bi-Directional KIR Promoters", Division of Hematology, Oncology, and Transplantation, Univ. Minnesota, MN

> Nov 2005 Invited Guest Speaker, "Stochastic Switches in Human and
> Mouse Class I MHC Receptor Genes: Remarkable Parallels, Intriguing
> Differences", Society of Natural Immunity Symposium, Poipu, HI
>
> Dec 2005 Invited Guest Speaker, "Probabilistic Switches",
> NCI-Frederick Faculty Seminar Series, Frederick, MD
>
> May 2006 Invited Guest Speaker, "Identification of Probabilistic
> Switches in the Human KIR Genes", AAI - Transcriptional Regulation of
> the Immune System Symposium, Boston, MA

[Present Address]{.underline}: 19931 Thacker Drive

Boonsboro, MD 21713

[BIBLIOGRAPHY]{.underline}

1\. Miller, J.L., Anderson, S.K., Fujita, D.J., Chaconas, G., Baldwin,
D., and Harshey, R.: The nucleotide sequence of the B gene of
bacteriophage Mu. [Nucleic Acids Res.]{.underline} 12: 8627-8638, 1984.

2\. Gibbs, C.P., Tanaka, A., Anderson, S.K., Radul, J., Baar, J.,
Ridgway, A., Kung, H-J., and Fujita, D.J.: Isolation and structural
mapping of a human c-*src* gene homologous to the transforming gene
(v-*src*) of Rous sarcoma virus. [J. Virol.]{.underline} 53: 19-24,
1985.

3\. Anderson, S.K., Gibbs, C., Tanaka, A., Kung, H-J., and Fujita, D.J.:
Human cellular *src* gene: nucleotide sequence and derived amino acid
sequence for the carboxy-terminal two-thirds of pp60c-*src*. [Mol. Cell.
Biol.]{.underline} 5: 1122-1129, 1985.

4\. Tanaka, A., Gibbs, C.P., Arthur, R.R., Anderson, S.K., Kung, H-J.,
and Fujita, D.J.: DNA sequence encoding the amino-terminal region of the
human c-*src* protein: implications of sequence divergence among
*src*-type kinase oncogenes. [Mol. Cell. Biol.]{.underline} 7:
1978-1983, 1987.

5\. Anderson, S.K. and Fujita, D.J.: Morph-f mutants of Rous sarcoma
virus: nucleotide sequencing suggests that a class of morph-f mutants
was generated through splicing of a cryptic intron. [J.
Virol.]{.underline} 61: 1895-1900, 1987.

6\. Anderson, S.K., Hong, K.Y., Hoskin, D.W., Abramow-Newerly, W.,
Fulop, G.M., Philips, R.A., Hozumi, N., and Roder, J.C.: Murine
lymphocytes with natural killer activity express CTL-derived serine
protease genes. [Immunol.]{.underline} 67: 269-273, 1989.

7\. Hoskin, D.W., Stankova, J., Anderson, S.K., and Roder, J.: A
functional and phenotypic comparison of murine natural killer (NK) cells
and lymphokine-activated killer (LAK) cells. [Intl. J.
Cancer]{.underline} 43: 940-948, 1989.

8\. Hoskin, D.W., Stankova, J., Anderson, S.K., and Roder, J.:
Amelioration of experimental lung metastasis in mice by therapy with
anti-CD3 monoclonal antibodies. [Cancer Immunol.
Immunother.]{.underline} 29: 226-230, 1989.

9\. Anderson, S.K., Stankova, J., and Roder, J.C.: Decreased p21 levels
in anti-sense ras transfectants augments NK sensitivity. [Mol.
Immunol.]{.underline} 26: 985-991, 1989.

10\. Raptis, L., Marcellus, R., Corbley, M.J., Krook, A., Whitfield, J.,
Anderson, S.K., and Haliotis, T.: Cellular *ras* gene activity is
required for full neoplastic transformation by polyomavirus. [J.
Virol.]{.underline} 65: 5203-5210, 1991.

11\. Hoskin, D.W., Anderson, S.K., Stankova, J., Haliotis, T., and
Roder, J.C.: Immunologic and non-immunologic consequences of the beige
mutation. In: [Genetically Based Immunological Disorders in Inbred
Mice]{.underline}, Rihova, B. and Vetvicka, V. (Eds), CRC Press, Boca
Raton, FL, 1991, pp. 251-263.

12\. Frey, J.L., Bino, T., Kantor, R.R.S., Segal, D.M., Giardina, S.L.,
Roder, J., Anderson, S., and Ortaldo, J.R.: Mechanism of target cell
recognition by natural killer cells: characterization of a novel
triggering molecule restricted to CD3^-^ large granular lymphocytes. [J.
Exp. Med.]{.underline} 174: 1527-1536, 1991.

13\. Anderson, S.K.: Molecular cloning of human and murine natural
killer cell tumor recognition proteins. In: [NK Cell Mediated
Cytoxicity: Receptors, Signaling and Mechanisms]{.underline}, Lotzova,
E. and Herberman, R. (Eds), CRC Press, Boca Raton, FL, 1992, pp. 1-23.

14\. Ying, L., Raptis, L., Anderson, S., Corbley, M.J., Zhou, Y-C.,
Pross, H., and Haliotis, T.: Ras modulates commitment and maturation of
10T½ fibroblasts to adipocytes. [Biochem. Cell. Biol.]{.underline} 70:
1249-1257, 1992.

15\. Anderson, S.K., Gallinger, S., Roder, J., Frey, J., Young, H., and
Ortaldo, J.: A novel cyclophilin-related protein involved in the
function of natural killer cells. [Proc. Natl. Acad. Sci.
USA]{.underline} 90: 542-546, 1993.

16\. Krook, A., Rapoport, M.J., Anderson, S., Pross, H., Zhou, Y-C.,
Denhardt, D.T., Delovitch, T.L., and Haliotis, T.: p21^ras^ and protein
kinase C function in distinct and interdependent signaling pathways in
C3H 10T½ fibroblasts. [Mol. Cell. Biol.]{.underline} 13: 1471-1479,
1993.

17\. Young, H.A., Jenkins, N.A., Copeland, N.G., Simek, S., Lerman,
M.I., Zbar, B., Glenn, G., Ortaldo, J.R., and Anderson, S.K.:
Localization of a novel natural killer triggering receptor locus to
human chromosome 3P23-p21 and mouse chromosome 9. [Genomics]{.underline}
16: 548-549, 1993.

18\. Rinfret, A. and Anderson, S.K.: IL-2 regulates the expression of
the NK-TR gene via an alternate RNA splicing mechanism. [Mol.
Immunol.]{.underline} 30: 1307-1313, 1993.

19\. Rinfret, A., Collins, C., Menard, R., and Anderson, S.K.: The
N-terminal cyclophilin homologous domain of a 150 kDa tumor recognition
molecule exhibits both peptidyl prolyl cis-trans isomerase (PPIase) and
chaperone activities. [Biochem.]{.underline} 33: 1668-1673, 1994.

20\. Chambers, C.A., Gallinger, S., Anderson, S.K., Giardina, S.,
Ortaldo, J.R., Hozumi, N., and Roder, J.: Expression of the NK-TR gene
is required for NK-like activity in human cells. [J.
Immunol.]{.underline} 152: 2669-2674, 1994.

21\. Giardina, S.L., Anderson, S.K., Sayers, T.J., Chambers, W.H.,
Palumbo, G.A., Young, H.A., and Ortaldo, J.R.: Selective loss of NK
cytotoxicity in antisense NK-TR1 rat LGL cell lines: abrogation of
antibody independent tumor and virus-infected target cell killing. [J.
Immunol.]{.underline} 154: 80-87, 1995.

22\. Mason, L.H, Ortaldo, J.R., Young, H.A., Kumar, V., Bennett, M., and
Anderson, S.K.: Cloning and functional characteristics of murine large
granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). [J.
Exp. Med.]{.underline} 182: 293-303, 1995.

23\. Giardina, S.L., Coffman, J.D., Young, H.A., Potter, S.J., Frey,
J.L., Ortaldo, J.R., and Anderson, S.K.: Association of the expression
of a SR-cyclophilin with myeloid cell differentiation.
[Blood]{.underline} 87: 2269-2274, 1996.

24\. Cox, G.W., Taylor, L.S., Willis, J.D., Melillo, G., White III,
R.L., Anderson, S.K., and Lin, J-J.: Molecular cloning and
characterization of a novel mouse macrophage gene that encodes a nuclear
protein comprising polyglutamine repeats and interspersing histidines.
[J. Biol. Chem.]{.underline} 271: 25515-25523, 1996.

25\. Nestel, F.P., Colwill, K., Harper, S., Pawson, T., and Anderson,
S.K.: RS cyclophilins: Identification of an NK-TR-related cyclophilin.
[Gene]{.underline} 180: 151-155, 1996.

26\. Mason, L. H., Anderson, S. K., Yokoyama, W. M., Smith, H. R. C.,
Winkler-Pickett, R., and Ortaldo, J. R.: The Ly-49D receptor activates
murine NK cells. [J. Exp. Med]{.underline}. 184: 2119-2128, 1996.

27\. Ortaldo, J.R., Mason, A.T., Mason, L.H., Winkler-Pickett, R.T.,
Gosselin, P., and Anderson, S.K.: Selective inhibition of human and
mouse NK-TR using retroviral anti-sense in primary NK cells: Involvement
with MHC class I killer cell inhibitory \[KIR\] receptors. [J.
Immunol.]{.underline} 158: 1262-1267, 1997.

28\. Simons-Evelyn, M., Young, H. A., and Anderson, S. K.:
Characterization of the mouse Nktr gene and promoter.
[Genomics]{.underline} 40: 94-100, 1997.

29\. Mason, L.H., Gosselin, P., Anderson, S.K., Fogler, W.E., Ortaldo,
J.R., and McVicar, D.W.: Differential tyrosine phosphorylation of
inhibitory versus activating Ly-49 receptor proteins and the recruitment
of SHP-1 phosphatase. [J. Immunol.]{.underline} 159: 4187-4196, 1997.

30\. Raptis, L., Brownell, H.L., Lu, Y., Preston, T., Narsimhan, R.P.,
Anderson, S., Schaefer, E., and Haliotis, T.: v-Ras and v-Raf
differentiation of transformable C3H 10T1/2-derived preadipocytes at
lower levels than required for neoplastic transformation. [Exp. Cell
Res.]{.underline} 235: 188-197, 1997.

31\. Mason, L.H., Willette-Brown, J., Anderson, S.K., Gosselin, P.,
Shores, E.W., Love, P.E., Ortaldo, J.R., and McVicar, D.W.: Cutting
Edge: Characterization of an associated 16-kDa tyrosine phosphoprotein
required for Ly-49D signal transduction. [J. Immunol.]{.underline} 160:
4148-4152, 1998.

32\. Vos, Q., Ortaldo, J.R., Conan-Cibotti, M., Vos, M.D., Young, H.A.,
Anderson, S.K., Witherspoon, K., Prager, I., Snapper, C.M., and Mond,
J.J.: Phenotypic and functional characterization of a panel of cytotoxic
murine NK cell clones that are heterogeneous in their enhancement of Ig
secretion in vitro. [Int. Immunol.]{.underline} 10: 1093-1101, 1998.

33\. McVicar, D.W., Taylor, L.S., Gosselin, P., Willette-Brown, J.,
Mikhael, A.I., Nakamura, M.C., Linnemeyer, P., Seaman, W.E., Anderson,
S.K., Ortaldo, J.R., and Mason, L.H.: DAP12 mediated signal transduction
in NK cells: a dominant role for the Syk protein tyrosine kinase. [J.
Biol. Chem.]{.underline} 273: 32934-32942, 1998.

34\. Yu, C.R., Ortaldo, J.R., Curiel, R.E., Young, H.A., Anderson, S.K.,
and Gosselin, P.: Role of a STAT binding site in the regulation of the
human perforin promoter. [J. Immunol.]{.underline} 162: 2785-2790, 1999.

35\. Gosselin, P., Mason, L.H., Willette-Brown, J., Ortaldo, J.R.,
McVicar, D.W., and Anderson, S.K.: Induction of DAP 12 phosphorylation,
calcium mobilization, and cytokine secretion by Ly49H. [J. Leukoc.
Biol.]{.underline} 66: 165-171, 1999.

36\. Makriannis, A.P., Gosselin, P., Mason, L.H., Taylor, L.S., McVicar,
D.W., Ortaldo, J.R., and Anderson, S.K.: Cloning and characterization of
a novel activating Ly49 closely related to Ly49A. [J.
Immunol.]{.underline} 163: 4931-4938, 1999.

37\. Ortaldo, J.R., Winkler-Pickett, R., Willette-Brown, J. Wange, R.J.,
Anderson, S.K., Palumbo, G.J., Mason, L.H., and McVicar, D.:
Structure/function relationship of activating Ly-49D and inhibitory
Ly-49G2 NK receptors. [J. Immunol.]{.underline} 163: 5269-5277, 1999.

38\. Gosselin, P., Makrigiannis, A.P., Nalewaik, R., and Anderson, S.K.:
Characterization of the Ly49I promoter. [Immunogenetics]{.underline} 51:
326-331, 2000.

39\. Makrigiannis, A.P. and Anderson, S.K.: Ly49 gene expression in
different inbred mouse strains. [Immunol. Res.]{.underline} 21: 39-47,
2000.

40. Makrigiannis, A.P., Etzler, J., Winkler-Pickett, R., Mason, A.,
    Ortaldo, J.R., and Anderson, S.K.: Identification of the Ly49L
    protein: Evidence for activating counterparts to inhibitory Ly49s.
    [J. Leukoc. Biol.]{.underline} 68: 765-771, 2000.

41. Makrigiannis, A.P. and Anderson, S.K.: The murine Ly49 family: form
    and function. [Archivum Immunologiae et Therapiae
    Experimentalis]{.underline} 49: 47-50, 2001.

42. Makrigianis, A.P., Pau, A.T., Saleh, A., Winkler-Pickett, R.,
    Ortaldo, J.R., and Anderson, S.K.: Class I MHC binding
    characteristics of the 129/J Ly49 repertoire.
    [J.Immunol.]{.underline} 166: 5034-5043, 2001.

43. Makrigiannis, A.P. and Anderson, S.K.: Mechanisms controlling the
    expression and diversity of the Ly49 gene family. [Mod. Asp.
    Immunobiol.]{.underline} 1: 228-232, 2001.

44. Anderson, S.K., Ortaldo, J.R., and McVicar, D.W.: The ever-expanding
    Ly49 gene family: repertoire and signaling. [Immunol.
    Rev.]{.underline} 181: 79-89, 2001.

45. Saleh, A., Makrigiannis, A.P., Hodge, D.L. and Anderson, S.K.:
    Identification of a novel Ly49 promoter that is active in bone
    marrow and fetal thymus. [J. Immunol.]{.underline} 168: 5163-5169,
    2002.

46. McVicar, D.W., Winkler-Pickett, R., Taylor, L.S., Makrigiannis, A.,
    Bennett, M., Anderson, S.K., and Ortaldo, J.R.: Aberrant Dap12
    signaling in the 129 strains of mice: implications for the analysis
    of gene targeted mice. [J. Immunol.]{.underline} 169: 1721-1728,
    2002.

47. Makrigiannis, A.P., Pau, A.T., Schwartzberg, P.L., McVicar, D.W.,
    Beck, T.W., and Anderson, S.K.: A BAC contig map of the Ly49 gene
    cluster in 129 mice reveals extensive differences in gene content
    relative to C57BL/6 mice. [Genomics]{.underline} 79: 437-444, 2002.

48. Mason, L.H., Willette-Brown, J., Anderson, S.K., Alvord, W.G.,
    Klabansky, R.L., Young, H.A., and Ortaldo, J.R.: Receptor
    glycosylation regulates Ly-49 binding to MHC Class I. [J.
    Immunol.]{.underline} 171: 4235-4242, 2003.

49. Makrigiannis, A.P., and Anderson, S.K.: Regulation of natural killer
    cell function. [Cancer Biol. & Ther.]{.underline} 2: 610-616, 2003.

50. Makrigiannis, A.P., Rouselle, E., and Anderson, S.K.: Independent
    control of Ly49g alleles: implications for NK cell repertoire
    selection and tumor cell killing. [J. Immunol.]{.underline} 172:
    414-1425, 2004.

51. Saleh, A., Davies, G.E., Pascal, V., Wright, P.W., Hodge, D.L., Cho,
    E.H., Lockett,S.J., Abshari, M., and Anderson, S.K.: Identification
    of probabilistic transcriptional switches in the Ly49 gene cluster:
    a eukaryotic mechanism for selective gene activation.
    [Immunity]{.underline} 21: 1-20, 2004.

52. Makrigiannis, A.P., Patel, D., Goulet, M-L., Dewar K., and Anderson,
    S.K.: Direct sequence comparison of two divergent class I MHC
    natural killer cell receptor haplotypes. [Genes and
    Immunity]{.underline} 6: 71-83, 2005.

53. Anderson, S.K., Dewar, K., Goulet, M-L, Leveque, G., and
    Makrigiannis, A.P.: Complete elucidation of a minimal class I MHC
    natural killer cell receptor haplotype. [Genes Immunity]{.underline}
    6: 481-492, 2005.

54. Anderson, S.K. and Makrigiannis, A.P.: Ly49B. [AfCS-Nature Molecule
    Pages]{.underline}. (Doi:10.1038/mp.a001421.01), 2005.

55. Makrigiannis, A.P. and Anderson, S.K.: Ly49C. [AfCS-Nature Molecule
    Pages]{.underline}. (Doi:10.1038/mp.a001422.01), 2005.

56. Makrigiannis, A.P., McVicar, D.W., and Anderson, S.K.: Ly49D.
    [AfCS-Nature Molecule Pages]{.underline}.
    (Doi:10.1038/mp.a001423.01), 2005.

57. Anderson, S.K. and Makrigiannis, A.P.: Ly49A. [AfCS-Nature Molecule
    Pages]{.underline} (DOI: 10.1038/mp.a001420.01), 2005.

58. Anderson, S.K.: Transcriptional regulation of NK cell receptors.
    [Current Topics Microbiol. Immunol.]{.underline} 298: 59-75, 2006.

59\. Anderson, S.K. and Makrigiannis, A.P.: Ly49G. [AfCS-Nature Molecule
Pages]{.underline}. (doi:10.1038/mp.a001426.01), 2006.

60\. Anderson, S.K. and. Makrigiannis, A.P.: Ly49H. [AfCS-Nature
Molecule Pages]{.underline}. (doi:10.1038/mp.a001427.01), 2006.

61\. Anderson, S.K. and Makrigiannis, A.P.: Ly49T. [AfCS-Nature Molecule
Pages]{.underline}. (doi:10.1038/mp.a002586.01), 2006.

62\. Number range CHAPTERAnderson, S.K. and Makrigiannis, A.P.:Ly49Q.
[AfCS-Nature Molecule Pages]{.underline} (Doi: 10.1038/mp.a002585.01),
2006.

63\. Number range CHAPTERPascal, V., Stulberg, M.J., and Anderson, S.K.:
Regulation of class I major histocompatibility complex receptor
expression in natural killer cells: one promoter is not enough!
[Immunol. Rev]{.underline}. 214: 9-21, 2006.

64\. Number range CHAPTERDavies, G.E., Locke, S.M., Wright, P.W., Li,
H., Hanson, R.J., Miller, J.S., and Anderson, S.K.: Identification of
bidirectional promoters in the human KIR genes. [Genes
Immunity]{.underline} 1-9, 2007.

65\. Number range CHAPTERIvanova, A., Ivanov, S., Pascal, V., Lumsden,
J., Ward, J., Morris, N., Tessarolo, L., Anderson, S., and Lerman, M.:
Autoimmunity, spontaneous tumorigenesis, and IL-15 insufficiency in mice
with a targeted disruption of the tumour suppressor gene *FusI.* [J.
Pathol]{.underline}. 211: 591-607, 2007.

67\. Number range CHAPTERStulberg, M.J., Wright, P.W., Dang, H., Hanson,
R.J., Miller, J.S. and Anderson, S.K.: Identification of distal KIR
promoters and transcripts. [Genes Immun]{.underline}**.** 8: 124-130,
2007.

[IN PRESS]{.underline}

1.  Anderson, S.K. and Makrigiannis, A.P.: Killer cell lectin-like
    receptor, subfamily A, member 9; Klra9; Ly49I. [AfCS-Molecular Pages
    (2006)]{.underline}.

```{=html}
<!-- -->
```
1.  Anderson, S.K. and Makrigiannis, A.P.: Killer cell lectin-like
    receptor, subfamily A, member 10; Klra10; Ly49. [AfCS-Molecular
    Pages (2006)]{.underline}.

2.  Number range CHAPTERWhittaker, G.C., Anderson, S.K., and McVicar,
    D.W.: DAP12. [AfCS-Nature Molecular Pages]{.underline}, in press.

[SUBMITTED]{.underline}

1\. Number range CHAPTERAnderson, S.K. and Makrigiannis, A.P.:Ly49L.
[AfCS-Nature Molecule Pages]{.underline}), 2006.

2\. Anderson, S.K. and Makrigiannis, A.P.:Ly49O. [AfCS-Nature Molecule
Pages]{.underline}), 2006.

3.  Anderson, S.K. and Makrigiannis, A.P.:Ly49P. [AfCS-Nature Molecule
    Pages]{.underline}), 2006.

4.  Anderson, S.K. and Makrigiannis, A.P.:Ly49V. [AfCS-Nature Molecule
    Pages]{.underline}), 2006.

5.  Anderson, S.K. and Makrigiannis, A.P.:Ly49W. [AfCS-Nature Molecule
    Pages]{.underline}), 2006.

7\. Number range CHAPTERPascal, V., Abshari, M., Siebenlist, U.,
Anderson, S.K.: NF-γF p50/p65 affects Natural Killer cell development by
regulating the expression of the Ly49 genes. **[Will be re-submitted to
J. Immunology.]{.underline}**

8\. Number range CHAPTERPascal, V., Yamada, E., Martin, M.P., Alter, G.,
Altfeld, M., Metcalf, J.A., Baseler, M.W., Adelsberger, J.W.,
Carrington, M., Anderson, S.K., and McVicar, D.W.: Detection of KIR3DS1
on the cell surface of peripheral blood NK cells facilitates
identification of a novel null allele and assessment of
[KIR3DS1]{.underline} expression during HIV-1 infection. **[Re-Submitted
to JI, 4/23/07.]{.underline}**